IP Cases — 2025
5,670 decisions across all jurisdictions
Page 75 of 189 · 5,670 total
Astha Jain & Anr. v.Ashok Kumar John Doe & Ors.
The Delhi High Court granted urgent interim relief in favor of the plaintiffs against various traders accused of selling counterfeit goods. The court found a prima facie case of trademark infringement, passing off, and copyright violation concerning the marks 'AYUVYA', 'i-GAIN+', 'IMFRESH', and 'BOOBEAUTIFUL'. Consequently, all defendants were restrained from using these impugned marks until further hearing, and specific directions were issued to take down product listings from major e-commerce platforms.
Abbott Products Operations Ag v.Ms. Aprajita Sushma Proprietor Of Alrom Pharmaceuticals Pvt. Ltd.
The Delhi High Court addressed multiple applications in the trademark dispute involving Abbott Products Operations Ag and Alrom Pharmaceuticals. The court allowed the petitioner's application seeking leave to file additional documents, while simultaneously initiating proceedings for a rectification petition concerning the 'KREOFLAT' trademark. This order sets out timelines for both parties to file replies and written synopses, moving the core dispute forward.
Sanofi SA and Others v.Reddy Pharma SAS, betapharm Arzneimittel GmbH, and Dr Reddy's Srl
This is a procedural order from the Local Division Munich of the Unified Patent Court concerning infringement actions related to European patent n° 2 493 466. The order, issued following an interim conference on 17 July 2025, addresses procedural matters including the timeline for the oral hearing, expert testimony on obviousness, and confidentiality issues regarding interim damages calculations. The court confirmed the oral hearing dates of 14–17 October 2025 and the final interim conference for 12 September 2025.
Sanofi SA and related Sanofi entities v.Accord Healthcare entities and related defendants
This is a procedural order issued by the Local Division Munich of the Unified Patent Court on 17 July 2025, following an interim conference in consolidated infringement actions concerning European patent n° 2 493 466. The order addresses procedural matters including the pending written reasoned decision from the EPO Board of Appeal (which upheld the patent as granted at an oral hearing on 2-4 June 2025), the scheduling of the oral hearing for 14-17 October 2025, expert testimony on obviousness issues related to the Phase III TROPIC study, and confidentiality arrangements regarding interim damages calculations. The claimants are various Sanofi entities, and the defendants comprise four groups: Accord Healthcare entities, STADA entities, Reddy Pharma/betapharm/Dr Reddy's entities, and Zentiva entities.
Faro Technologies, Inc. v.PMT Technologies (Suzhou) Co., Ltd. and Blankenhorn GmbH
The Local Chamber Mannheim of the Unified Patent Court denied a request by Respondent PMT Technologies (Suzhou) Co., Ltd. to postpone the oral hearing scheduled for September 1, 2025 in proceedings concerning European Patent EP 4 001 835. The court held that the urgency inherent in interim measure proceedings requires very special circumstances for postponement, and that vacation absences of legal and patent attorney representatives do not constitute such circumstances. The court also offered the parties the opportunity to raise objections to Respondent 1 participating in the hearing via video link by July 24, 2025.
FUJIFILM Corporation v.Kodak GmbH, Kodak Graphic Communications GmbH, Kodak Holding GmbH
This order from the Mannheim Local Division concerns enforcement proceedings following a main decision of 2 April 2025 finding infringement of EP 3 511 174. The defendants (Kodak entities) sought confidentiality protection under Rule 262A RoP for information they were required to disclose during enforcement. The court rejected the request, holding that the defendants should have raised confidentiality in the main proceedings, that the main decision already restricted use of the information to the stated purposes, and that no specific risk of misuse was demonstrated.
Sanofi SA and related Sanofi entities v.Accord Healthcare, STADA, Reddy Pharma, and Zentiva entities
This is a procedural order from the Local Division Munich of the Court of First Instance concerning four related infringement actions involving European Patent No. 2 493 466. The order, issued following an interim conference, addresses procedural matters including the pending written reasoned decision from the EPO Board of Appeal (which upheld the patent as granted at an oral hearing on 2-4 June 2025), the scheduling of expert testimony via hot tubbing on obviousness issues, confidentiality arrangements regarding Sanofi's damages calculations, and the format of Sanofi's future briefs. The court confirmed dates for the final interim conference (12 September 2025) and the oral hearing (14-17 October 2025).
Sanofi SA and related Sanofi entities v.Accord Healthcare, STADA, Reddy Pharma, and Zentiva entities
Procedural order issued by the Local Division Munich of the Unified Patent Court following an interim conference in patent infringement actions concerning European patent EP 2 493 466. The order addresses pending issues including the awaited written reasoned decision from the EPO Board of Appeal (which upheld the patent at an oral hearing in June 2025), ongoing French appeal proceedings regarding invalidation of the French part of the patent, and preparations for the oral hearing scheduled for October 2025. The court confirmed dates for the final interim conference and oral hearing, and addressed procedural matters including confidentiality of interim damages calculations and the format of Sanofi's briefs.
Samsung Electronics Co. Ltd. et al. v.Maxell, LTD.
Maxell defends its ’650 Patent on personalized content delivery, arguing that Samsung’s cited prior art (Shindo, Sasaki, Futa, McClellan) does not teach the claimed one‑to‑one content‑to‑device mapping. The response also challenges the petitioner's expert credibility and claim construction.
Samsung Electronics Co. Ltd. et al. v.Maxell, LTD.
Maxell’s preliminary response argues Samsung’s IPR petition fails because the cited prior art (Shindo, Sasaki, Futa, McClellan) does not disclose the patented association‑information features. The patent owner seeks denial of institution.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung and Radian Memory Systems settled their IPR dispute over patent 11,709,772 B1 before trial. The Board granted the joint motion to terminate, ending the proceeding.
Samsung Electronics Co., Ltd. et al. v.Maxell, LTD.
Maxell filed a sur‑reply opposing Samsung’s IPR petition on U.S. Patent 10,812,646, asserting that the petition is vague, lacks claim constructions, and misstates the patent owner’s position on the “sleep state.” The patent owner urges the Board to deny institution.
Samsung Electronics Co., Ltd. et al. v.Maxell, LTD.
Maxell contests Samsung’s IPR petition on U.S. Patent 10,812,646, arguing that the cited prior art does not disclose the three distinct display modes claimed. The patent owner seeks denial of institution, asserting no reasonable likelihood of success for Samsung.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung and Radian have entered a confidential settlement and jointly moved to terminate IPR2025-01321 under 35 U.S.C. § 317(a). The motion stresses public‑policy benefits of early settlement and resource conservation.
Samsung Electronics Co. Ltd. et al. v.Maxell, LTD.
Maxell’s preliminary sur‑reply rebuts Samsung’s IPR petition, asserting that the patent’s “association information” requirement is not satisfied by Samsung’s prior‑art references. The patent owner emphasizes the need for a storage element that actually stores the association data, which Samsung’s citations lack.
Election Systems & Software, LLC v.Hart InterCivic, Inc.
Election Systems & Software petitions to invalidate Hart InterCivic’s 12,125,319 patent, asserting that its claims are abstract, obvious over prior‑art voting‑machine technology, and lack written description for recursive features.
Samsung Electronics Co. Ltd. et al. v.Maxell, LTD.
Samsung Electronics filed an IPR petition seeking cancellation of claims 1‑4 of Maxell’s U.S. Patent 11,277,650. The petition argues the claims are obvious over three prior‑art references—Shindo, Sasaki, and a combination of Futa and McClellan—under 35 U.S.C. §103. The petition requests that all challenged claims be found unpatentable.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung has filed an IPR petition challenging Radian Memory’s ’772 SSD management patent, asserting that its claims are obvious over a suite of prior‑art references. The petition seeks to invalidate the claims covering zone‑based flash memory techniques.
Cytek Biosciences, Inc. v.Beckman Coulter, Inc. et al.
Cytek Biosciences has filed an IPR petition challenging 14 claims of Beckman Coulter’s 2023 flow‑cytometer patent, asserting obviousness over prior‑art WDM designs by Goodman and Oostman.
Samsung Electronics Co., Ltd. et al. v.Maxell, LTD.
Samsung has filed an IPR petition seeking cancellation of all 25 claims of Maxell’s ’646 patent, arguing that the claimed smartphone remote‑control features are obvious over prior‑art devices such as Esaka, Guihot, Bandyopadhyay and Sharif‑Ahmadi.
Election Systems & Software, LLC v.Hart InterCivic, Inc.
The USPTO Board denied institution for PGR2025-00066 after reviewing the merits. The denial was based on the petitioner failing to demonstrate a reasonable likelihood of prevailing or that the claims were unpatentable.
Samsung Electronics Co., Ltd. et al. v.Maxell, LTD.
The PTAB denied institution for Samsung against Maxell's patent 10812646 after a merits review, finding the petitioner failed to meet the likelihood of prevailing standard.
Samsung Electronics Co. Ltd. et al. v.Maxell, LTD.
The PTAB granted institution for IPR2025-01308 involving Samsung Electronics Co. Ltd. and Maxell, LTD., allowing the dispute over patent 11277650 to proceed to trial.
Nokia Technologies Oy v.Assistant Controller Of Patents And Designs
Nokia Technologies Oy filed an appeal under Section 117A(2) of the Patents Act, 1970, challenging the rejection of its patent application no. 201917042060 by the Assistant Controller of Patents and Designs. The appellant also sought condonation for a delay of 53 days in filing the appeal.
E3D A.C. A. L. v.Assistant Controller of Patents and Designs
The appellant filed an appeal challenging the order passed by the respondent on January 27, 2025, which refused the Indian patent application titled 'MULTIPLE USE COMPUTERIZED INJECTOR'. The court first allowed the application seeking condonation of a 33-day delay in filing the appeal and granted exemptions for documentation.
Vikas Abhimanyu Gupta v.Dive Marketing Private Limited
In this interim application concerning a commercial IP suit, the Bombay High Court addressed the respondent's willingness to withdraw certain trademarks. The court directed the respondent to file an affidavit from its responsible officer within one week, indicating that the matter is proceeding through procedural steps rather than a final judgment on infringement or validity.
Sun Pharmaceutical Industries Ltd & Anr. v.Janricsan Pharma P Ltd & Ors.
The Delhi High Court granted an interim injunction in favor of Sun Pharmaceutical Industries Ltd against Janricsan Pharma P Ltd. The court found a prima facie case for trademark infringement, noting the potential for dangerous public confusion due to the similarity between the parties' pharmaceutical product names. This protective order restrains the defendants from manufacturing or selling products under marks deemed deceptively similar to the plaintiffs' registered trademarks until the final hearing.
M/s. Ttk Prestige Limited v.Mr. Kailashkumar Punmaji Mali
In a case involving trademark and copyright infringement, M/s. TTK Prestige Limited successfully reached a memorandum of compromise with the defendant, Mr. Kailashkumar Punmaji Mali. The court accepted this settlement, decreeing the suit in its favor. Crucially, the judgment also allowed all rectification petitions filed by the plaintiff, leading to the expungement of several deceptively similar trade mark and copyright registrations from the respective registries.
Mr. Bhushanam Rayelly / M/s.Living Seed Technologies LLP v.M/s.Karthikeya Crop Technologies
The Madras High Court allowed the petition seeking rectification of the Trade Marks Register, directing the removal of an impugned trademark (No. 4972011). The court found that the petitioner had been using their mark ('SUPER AMAN') continuously since 2009 for agricultural products like paddy, establishing prior use. Given the striking similarity between the marks and the likelihood of consumer confusion, the registration granted to the respondent was deemed without sufficient cause.
Lotus Herbals Private Limited v.Nishtu Enterprises & Ors.
The Delhi High Court allowed Lotus Herbals Private Limited to implead a new entity, Jhalak Cosmetics Store, as a defendant in its trademark infringement suit. This decision was based on the plaintiff's discovery that the new store was selling counterfeit products using the infringing 'LOTUS' mark and trade dress. Furthermore, the court extended the existing interim injunction to this newly added defendant and granted extensive powers to a Local Commissioner to conduct search, seizure, and document examination at the premises of the infringer.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.